Relevium Technologies Completes Shares-For-Debt Transactions
October 01, 2021 14:47 ET
|
Relevium Technologies Inc
MONTREAL, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce that it has completed...
Relevium Obtains Conditional TSXV Approval for the Settlement of the Outstanding Notes in Shares
August 10, 2021 09:48 ET
|
Relevium Technologies Inc
MONTREAL, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today it has received conditional...
Relevium Announces Settlement of the Outstanding Notes
June 30, 2021 11:19 ET
|
Relevium Technologies Inc
MONTREAL, June 30, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announces today it has reached an agreement to...
Relevium Announces Shareholder Townhall and Conference Call
June 15, 2021 10:11 ET
|
Relevium Technologies Inc
MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to invite all shareholders,...
Relevium Announces Maturity of the Outstanding Convertible Debenture Notes and Begins Negotiations With Debenture Holders
June 10, 2021 08:11 ET
|
Relevium Technologies Inc
MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announces today the maturity of its...
Relevium Announces the Appointment of Dr. Wolfgang Renz as Chief Scientific Officer for Biocannabix Health Corporation
May 20, 2021 02:00 ET
|
Relevium Technologies Inc
MONTREAL, May 20, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), and its’ wholly-owned subsidiary, Biocannabix...
Relevium Provides Update on the Exclusive Supply of Medical Examination Gloves
May 05, 2021 09:47 ET
|
Relevium Technologies Inc
MONTREAL, May 05, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), whose primary mandate is to focus on...
Biocannabix Enters Into LOI With IAM Health GmbH
April 29, 2021 09:12 ET
|
Relevium Technologies Inc
MONTREAL, April 29, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), and its’ wholly-owned subsidiary, Biocannabix...
Relevium Secures North American Exclusivity for Medical Examination Gloves, with First Shipment to Arrive in Los Angeles by Mid April
March 11, 2021 13:59 ET
|
Relevium Technologies Inc
MONTREAL, March 11, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the company has...
Relevium Announces Investor Relations Conference Call
February 04, 2021 16:48 ET
|
Relevium Technologies Inc
MONTREAL, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to invite all shareholders,...